2ND TUMORS AFTER BREAST-CANCER - IS IT STILL TOO SOON TO TELL

被引：2

作者：

CASTIGLIONE, M ^{[1
]}

GOLDHIRSCH, A ^{[1
]}

机构：

[1] INT BREAST CANC STUDY GRP,LUGANO,SWITZERLAND

来源：

ANNALS OF ONCOLOGY | 1994年 / 5卷 / 09期

关键词：

D O I：

10.1093/oxfordjournals.annonc.a059004

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：785 / 787

页数：3

共 19 条

[1] ADJUVANT CHEMOTHERAPY IN EARLY BREAST-CANCER AND INCIDENCE OF NEW PRIMARY MALIGNANCIES [J].

ARRIAGADA, R ;

RUTQVIST, LE .

LANCET, 1991, 338 (8766) :535-538

[2] RISK OF LEUKEMIA AFTER CHEMOTHERAPY AND RADIATION TREATMENT FOR BREAST-CANCER [J].

CURTIS, RE ;

BOICE, JD ;

STOVALL, M ;

BERNSTEIN, L ;

GREENBERG, RS ;

FLANNERY, JT ;

SCHWARTZ, AG ;

WEYER, P ;

MOLONEY, WC ;

HOOVER, RN .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (26) :1745-1751

[3]

CURTIS RE, 1984, J NATL CANCER I, V72, P531

[4]

DALY PA, 1992, ANN ONCOL, V3, P10

[5]

Ewertz M, 1985, Natl Cancer Inst Monogr, V68, P325

[6]

FINCH SC, 1984, PROGR CANCER RES THE, V26, P37

[7] LEUKEMIA IN BREAST-CANCER PATIENTS FOLLOWING ADJUVANT CHEMOTHERAPY OR POSTOPERATIVE RADIATION - THE NSABP EXPERIENCE [J].

FISHER, B ;

ROCKETTE, H ;

FISHER, ER ;

WICKERHAM, DL ;

REDMOND, C ;

BROWN, A .

JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (12) :1640-1658

[8]

FOMANDER T, 1989, LANCET, V1, P117

[9] MELPHALAN MAY BE A MORE POTENT LEUKEMOGEN THAN CYCLOPHOSPHAMIDE [J].

GREENE, MH ;

HARRIS, EL ;

GERSHENSON, DM ;

MALKASIAN, GD ;

MELTON, LJ ;

DEMBO, AJ ;

BENNETT, JM ;

MOLONEY, WC ;

BOICE, JD .

ANNALS OF INTERNAL MEDICINE, 1986, 105 (03) :360-367

[10]

Harvey E B, 1985, Natl Cancer Inst Monogr, V68, P99

← 1 2 →